/2367.HK
2367.HK Stock - Giant Biogene Holding Co., Ltd.
Consumer Defensive|Household & Personal ProductsHKSE
$35.64-0.28%
$0.10 (-0.28%) • Dec 24
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $39.20
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 2367.HK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$35.28 – $36.00
TARGET (TP)$40.99
STOP LOSS$32.79
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.62
52W High$87.10
52W Low$34.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.54B | $3.52B | $2.36B | $1.55B | $1.19B |
| Gross Profit | $4.55B | $2.95B | $2.00B | $1.35B | $1.01B |
| Gross Margin | 82.1% | 83.6% | 84.4% | 87.2% | 84.6% |
| Operating Income | $2.31B | $1.66B | $1.13B | $914.57M | $806.75M |
| Net Income | $2.06B | $1.45B | $1.00B | $828.13M | $826.45M |
| Net Margin | 37.2% | 41.2% | 42.4% | 53.3% | 69.4% |
| EPS | $2.10 | $1.49 | $0.99 | $0.84 | $0.83 |
Company Overview
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
2367.HKBeat Rate
60%
Last 5 quarters
Avg Surprise
+0.3%
EPS vs Estimate
Beats / Misses
3/1
1 met exactly
Latest EPS
$1.23
Q3 2025
EPS Surprise History
Q4 21
No data
Q4 22
No data
Q1 23
-23.0%
$0.44vs$0.58
Q3 23
No data
Q1 24
+8.3%
$0.91vs$0.84
Q3 24
+15.2%
$1.04vs$0.90
Q1 25
+0.9%
$1.15vs$1.14
Q3 25
0.0%
$1.23vs$1.23
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 26, 2026 | — | — | — | — |
Q3 2025 | Aug 27, 2025 | $1.23 | $1.23 | 0.0% | = MET |
Q1 2025 | Mar 26, 2025 | $1.14 | $1.15 | +0.9% | ✓ BEAT |
Q3 2024 | Aug 19, 2024 | $0.90 | $1.04 | +15.2% | ✓ BEAT |
Q1 2024 | Mar 26, 2024 | $0.84 | $0.91 | +8.3% | ✓ BEAT |
Q3 2023 | Aug 28, 2023 | — | $0.72 | — | — |
Q1 2023 | Mar 27, 2023 | $0.58 | $0.44 | -23.0% | ✗ MISS |
Q4 2022 | Oct 24, 2022 | — | $0.34 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.51 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.50 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.49 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.46 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.32 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.32 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 2367.HK
What is 2367.HK's current stock price?
Giant Biogene Holding Co., Ltd. (2367.HK) is currently trading at $35.64 per share. The stock has moved -0.28% today.
What is the analyst price target for 2367.HK?
No analyst price targets are currently available for this stock.
What sector is Giant Biogene Holding Co., Ltd. in?
Giant Biogene Holding Co., Ltd. operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the HKSE exchange.
What is 2367.HK's market cap?
Giant Biogene Holding Co., Ltd. has a market capitalization of $37.59 billion, making it a large-cap company.
Does 2367.HK pay dividends?
No, Giant Biogene Holding Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive Sector0142.HK
First Pacific Company Limited
$6.07
Mkt Cap: $25.8B
0220.HK
Uni-President China Holdings Ltd
$8.28
Mkt Cap: $35.8B
1044.HK
Hengan International Group Company Limited
$28.32
Mkt Cap: $32.9B
2145.HK
Shanghai Chicmax Cosmetic Co., Ltd.
$85.30
Mkt Cap: $34.0B
2460.HK
China Resources Beverage (Holdings) Co. Ltd.
$10.44
Mkt Cap: $25.0B
6055.HK
China Tobacco International (HK) Company Limited
$34.80
Mkt Cap: $24.1B
6186.HK
China Feihe Limited
$4.24
Mkt Cap: $38.4B
6979.HK
ZJLD Group Inc
$8.86
Mkt Cap: $30.0B
6993.HK
Blue Moon Group Holdings Limited
$2.80
Mkt Cap: $16.4B
9985.HK
WEILONG Delicious Global Holdings Ltd
$11.58
Mkt Cap: $28.2B
Explore stocks similar to 2367.HK for comparison